Kedalion Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 06, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,000,000
Company Info
- Founders
- Peter Noymer
- Company Description
- Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
- Market
- Ophthalmic therapies
- Location
- Menlo Park, CA, USA
- Coinvestors
- Lagunita Biosciences